DePuy Synthes launches tissue implant for spine surgery

DePuy Synthes Spine, in collaboration with DePuy Synthes Biomaterials, announced the U.S. launch of Conform Sheet, a hydrated, pliable and demineralized cancellous bone matrix that fills voids during posterolateral spinal fusion surgery and provides a natural scaffold for new bone formation.

According to a company press release, the new allograft implant has both osteoinductive and osteoconductive properties. Through a unique demineralization process, bone morphogenic proteins are exposed, providing Conform Sheet its osteoinductive properties, while the cancellous structure of the scaffold provides osteoconductive characteristics. Conform Sheet absorbs various hydrating fluids including bone marrow aspirate, blood or saline, and when combined with bone marrow aspirate, Conform Sheet becomes osteogenic.

Offered in four sizes, which may be cut to accommodate irregular shaped anatomy, the implant may be used with DePuy Synthes Spine Matrix MIS Pedicle Screw System and Expedium Spine System, as well as other systems for spinal fusion.

“We are pleased to collaborate across DePuy Synthes Companies with our Biomaterials colleagues to offer complete solutions that advance patient care,” Max Reinhardt, worldwide president of DePuy Synthes Spine, stated in the release.